Thursday, 2 December 2021

Australia's most trusted
source of pharma news

Thursday, 02 December 2021

PBAC, DoH leadership question

Posted 26 October 2021 AM

In what could be regarded as a thinly veiled swipe at the current hierachy in the Department of Health and PBAC, a submission to the National Medicines Policy Review (NMPR) has called for the re-introduction of the "strategic leadership" of times gone by and a "reset of the relationship" between the federal government and the medicines industry.

The joint submission by former MA boss Dr Brendan Shaw and academic Dr Orin Chisholm has called for the medicines industry to become a partner in the health of Australian patients - not merely a supplier of medicines in a transactional relationship.

To see the whole article, please login

Email this article to a friend

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.


Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.


Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).


You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.


You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.